Relief Therapeutics Holding SA (OTCMKTS:RLFTF) Short Interest Up 300.0% in March

Relief Therapeutics Holding SA (OTCMKTS:RLFTF) was the recipient of a significant growth in short interest in March. As of March 15th, there was short interest totalling 400 shares, a growth of 300.0% from the February 28th total of 100 shares. Based on an average trading volume of 3,200 shares, the days-to-cover ratio is presently 0.1 days.

Relief Therapeutics Stock Up 1.5 %

Shares of OTCMKTS RLFTF traded up $0.04 during midday trading on Friday, reaching $2.64. 115 shares of the company traded hands, compared to its average volume of 2,457. The stock’s 50-day simple moving average is $3.55 and its 200-day simple moving average is $4.45. Relief Therapeutics has a 12 month low of $1.10 and a 12 month high of $7.66.

About Relief Therapeutics

Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.